StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma cash

Cash and short-term investments held at the end of each period.

Cocrystal Pharma's cash was $2.17M at Jun 30, 2026. For fiscal 2025 it was $7.03M, down 28.8% from the year before. Over ten years it grew -2.7% a year on average. The highest annual figure on record is $58.71M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.03M-28.8%
FY2024Dec 31, 2024$9.86M-62.6%
FY2023Dec 31, 2023$26.35M-29.1%
FY2022Dec 31, 2022$37.14M-36.7%
FY2021Dec 31, 2021$58.71M+77.8%
FY2020Dec 31, 2020$33.01M+345.0%
FY2019Dec 31, 2019$7.42M+172.4%
FY2018Dec 31, 2018$2.72M+264.0%
FY2017Dec 31, 2017$748.00K-79.5%
FY2016Dec 31, 2016$3.64M-60.8%
FY2015Dec 31, 2015$9.28M+56.0%
FY2014Dec 31, 2014$5.95M+475.0%
FY2013Dec 31, 2013$1.03M-78.1%
FY2012Dec 31, 2012$4.72M+13236.9%
FY2011Dec 31, 2011$35.37K-85.9%
FY2010Dec 31, 2010$251.48K-57.2%
FY2009Dec 31, 2009$587.41K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.17M-54.5%
Q1 FY2026Mar 31, 2026$4.69M-32.3%
Q4 FY2025Dec 31, 2025$7.03M-28.8%
Q3 FY2025Sep 30, 2025$7.73M-40.6%
Q2 FY2025Jun 30, 2025$4.77M-73.7%
Q1 FY2025Mar 31, 2025$6.92M-68.3%
Q4 FY2024Dec 31, 2024$9.86M-62.6%
Q3 FY2024Sep 30, 2024$13.02M-56.2%
Q2 FY2024Jun 30, 2024$18.14M-44.0%
Q1 FY2024Mar 31, 2024$21.84M-35.7%
Q4 FY2023Dec 31, 2023$26.35M-29.1%
Q3 FY2023Sep 30, 2023$29.74M-29.3%
Q2 FY2023Jun 30, 2023$32.42M-36.5%
Q1 FY2023Mar 31, 2023$33.98M-38.0%
Q4 FY2022Dec 31, 2022$37.14M-36.7%
Q3 FY2022Sep 30, 2022$42.06M-31.8%
Q2 FY2022Jun 30, 2022$51.03M-23.9%
Q1 FY2022Mar 31, 2022$54.79M+64.6%
Q4 FY2021Dec 31, 2021$58.71M+77.8%
Q3 FY2021Sep 30, 2021$61.64M+94.0%
Q2 FY2021Jun 30, 2021$67.06M+247.2%
Q1 FY2021Mar 31, 2021$33.28M+53.5%
Q4 FY2020Dec 31, 2020$33.01M+345.0%
Q3 FY2020Sep 30, 2020$31.78M+430.2%
Q2 FY2020Jun 30, 2020$19.32M+158.4%
Q1 FY2020Mar 31, 2020$21.69M+153.0%
Q4 FY2019Dec 31, 2019$7.42M+172.4%
Q3 FY2019Sep 30, 2019$5.99M+28.0%
Q2 FY2019Jun 30, 2019$7.47M+9.3%
Q1 FY2019Mar 31, 2019$8.57M+586.2%
Q4 FY2018Dec 31, 2018$2.72M+264.0%
Q3 FY2018Sep 30, 2018$4.68M+248.3%
Q2 FY2018Jun 30, 2018$6.84M+98.2%
Q1 FY2018Mar 31, 2018$1.25M-19.7%
Q4 FY2017Dec 31, 2017$748.00K-79.5%
Q3 FY2017Sep 30, 2017$1.35M-77.2%
Q2 FY2017Jun 30, 2017$3.45M–
Q1 FY2017Mar 31, 2017$1.56M–
Q4 FY2016Dec 31, 2016$3.64M–
Q3 FY2016Sep 30, 2016$5.91M–

More Cocrystal Pharma figures

See a number that looks wrong?